rs4252105

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000301.5(PLG):​c.668+112T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 1,059,330 control chromosomes in the GnomAD database, including 81,153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.35 ( 9921 hom., cov: 33)
Exomes 𝑓: 0.39 ( 71232 hom. )

Consequence

PLG
NM_000301.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.928

Publications

7 publications found
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
  • hypoplasminogenemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • angioedema, hereditary, 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-160715026-T-A is Benign according to our data. Variant chr6-160715026-T-A is described in ClinVar as Benign. ClinVar VariationId is 1276813.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.434 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000301.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLG
NM_000301.5
MANE Select
c.668+112T>A
intron
N/ANP_000292.1P00747

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLG
ENST00000308192.14
TSL:1 MANE Select
c.668+112T>A
intron
N/AENSP00000308938.9P00747
PLG
ENST00000872438.1
c.668+112T>A
intron
N/AENSP00000542497.1
PLG
ENST00000872435.1
c.668+112T>A
intron
N/AENSP00000542494.1

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53724
AN:
152020
Hom.:
9919
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.509
Gnomad AMR
AF:
0.318
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.448
Gnomad SAS
AF:
0.400
Gnomad FIN
AF:
0.315
Gnomad MID
AF:
0.293
Gnomad NFE
AF:
0.410
Gnomad OTH
AF:
0.355
GnomAD4 exome
AF:
0.391
AC:
354341
AN:
907192
Hom.:
71232
AF XY:
0.394
AC XY:
184393
AN XY:
467850
show subpopulations
African (AFR)
AF:
0.246
AC:
5587
AN:
22704
American (AMR)
AF:
0.283
AC:
10389
AN:
36756
Ashkenazi Jewish (ASJ)
AF:
0.408
AC:
9052
AN:
22196
East Asian (EAS)
AF:
0.437
AC:
15109
AN:
34562
South Asian (SAS)
AF:
0.412
AC:
28943
AN:
70282
European-Finnish (FIN)
AF:
0.319
AC:
12565
AN:
39358
Middle Eastern (MID)
AF:
0.318
AC:
1017
AN:
3202
European-Non Finnish (NFE)
AF:
0.402
AC:
255620
AN:
636234
Other (OTH)
AF:
0.383
AC:
16059
AN:
41898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10884
21769
32653
43538
54422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5940
11880
17820
23760
29700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53740
AN:
152138
Hom.:
9921
Cov.:
33
AF XY:
0.351
AC XY:
26137
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.257
AC:
10678
AN:
41504
American (AMR)
AF:
0.318
AC:
4863
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1443
AN:
3468
East Asian (EAS)
AF:
0.449
AC:
2321
AN:
5170
South Asian (SAS)
AF:
0.400
AC:
1926
AN:
4816
European-Finnish (FIN)
AF:
0.315
AC:
3340
AN:
10594
Middle Eastern (MID)
AF:
0.305
AC:
89
AN:
292
European-Non Finnish (NFE)
AF:
0.410
AC:
27872
AN:
67978
Other (OTH)
AF:
0.353
AC:
746
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1782
3563
5345
7126
8908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.402
Hom.:
7134
Bravo
AF:
0.348
Asia WGS
AF:
0.381
AC:
1326
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.47
DANN
Benign
0.67
PhyloP100
-0.93
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4252105; hg19: chr6-161136058; API